SEARCH

SEARCH BY CITATION

References

  • 1
    Willis T. The London Practice of Physice, 1st edn. London: Thomas Bassett and William Crooke, 1685: 404.
  • 2
    Ekbom KA. Restless legs. Acta Medica Scandinavica 1945; 158: 5123.
  • 3
    American Academy of Sleep Medicine. Periodic limb movement disorder. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. Westchester, IL: American Academy of Sleep Medicine, 2005: 182186.
  • 4
    Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Movement Disorders 1995; 10: 634642.
  • 5
    Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine 2003; 4: 101119.
  • 6
    Walters AS, LeBrocq C, Dhar A, et al. International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Medicine 2003; 4: 121132.
  • 7
    Atkinson MJ, Allen RP, Du Chane J, Murray C, Kushida C, Roth T. RLS Quality of Life Consortium. Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation. Quality Life Research 2004; 13: 679693.
  • 8
    American Academy of Sleep Medicine. Restless legs syndrome. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. Westchester, IL: American Academy of Sleep Medicine, 2005: 178181.
  • 9
    Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004. European Journal of Neurology 2004; 11: 577581.
  • 10
    Wagner ML, Walters AS, Coleman RG, Hening WA, Grasing K, Chokroverty S. Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 1996; 19: 5258.
  • 11
    Inoue Y, Mitani H, Nanba K, Kawahara R. Treatment of periodic leg movement disorder and restless leg syndrome with talipexole. Psychiatry and Clinical Neurosciences 1999; 53: 283285.
  • 12
    Ausserwinkler M, Schmidt P. Erfolgreiche Behandlung des ‘restless legs’-Syndroms bei chronischer Niereninsuffizienz mit Clonidin. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine 1989; 119: 184186.
  • 13
    Telstad W, Sorensen O, Larsen S, Lillevold PE, Stensrud P, Hansen R. Treatment of the restless legs syndrome with carbamazepine: a double blind study. British Medical Journal (Clinical Research Edition) 1984; 288: 444446.
  • 14
    Lundvall O, Abom PE, Holm R. Carbamazepine in restless legs. A controlled pilot study. European Journal of Clinical Pharmacology 1983; 25: 323324.
  • 15
    Garcia-Borreguero D, Larrosa O, De La Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002; 59: 15731579.
  • 16
    Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin (Neurontin). Sleep 1996; 19: 224226.
  • 17
    Happe S, Klosch G, Saletu B, Zeitlhofer J. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001; 57: 17171719.
  • 18
    Happe S, Sauter C, Klosch G, Saletu B, Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 2003; 48: 8286.
  • 19
    Adler CH. Treatment of restless legs syndrome with gabapentin. Clinical Neuropharmacology 1997; 20: 148151.
  • 20
    Eisensehr I, Ehrenberg BL, Rogge-Solti S, Noachtar S. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid. Journal of Neurology 2004; 251: 579583.
  • 21
    Thorp ML, Morris CD, Bagby SP. A crossover study of gabapentin in treatment of restless legs syndrome among haemodialysis patients. American Journal of Kidney Diseases 2001; 38: 104108.
  • 22
    Freye E, Levy JV, Partecke L. Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD) – correlation with neurophysiological parameters. Neurophysiologie Clinique 2004; 34: 8189.
  • 23
    Montagna P, Sassoli-de-Bianchi L, Zucconi M, Cirignotta F, Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurologica Scandinavica 1984; 69: 428430.
  • 24
    Boghen D, Lamothe L, Elie R, Godbout R, Montplaisir J. The treatment of the restless legs syndrome with clonazepam: a prospective controlled study. Canadian Journal of Neurological Sciences 1986; 13: 245247.
  • 25
    Saletu M, Anderer P, Saletu-Zyhlarz G, et al. Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. European Neuropsychopharmacology 2001a; 11: 153161.
  • 26
    Mitler MM, Browman CP, Menn SJ, Gujavarty K, Timms RM. Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep 1986; 9: 385392.
  • 27
    Edinger JD, Fins AI, Sullivan RJ, Marsh GR, Dailey DS, Young M. Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. Sleep 1996; 19: 442444.
  • 28
    Ohanna N, Peled R, Rubin AH, Zomer J, Lavie P. Periodic leg movements in sleep: effect of clonazepam treatment. Neurology 1985; 35: 408411.
  • 29
    Peled R, Lavie P. Double-blind evaluation of clonazepam on periodic leg movements in sleep. Journal of Neurology, Neurosurgery, and Psychiatry 1987; 50: 16791681.
  • 30
    Inami Y, Horiguchi J, Nishimatsu O, et al. A polysomnographic study on periodic limb movements in patients with restless legs syndrome and neuroleptic-induced akathisia. Hiroshima Journal of Medical Sciences 1997; 46: 133141.
  • 31
    Arens R, Wright B, Elliott J, et al. Periodic limb movement in sleep in children with Williams syndrome. Journal of Pediatrics 1998; 133: 670674.
  • 32
    Doghramji K, Browman CP, Gaddy JR, Walsh JK. Triazolam diminishes daytime sleepiness and sleep fragmentation in patients with periodic leg movements in sleep. Journal of Clinical Psychopharmacology 1991; 11: 284290.
  • 33
    Bonnet MH, Arand DL. Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness. Aging 1991; 3: 313324.
  • 34
    Moldofsky H, Tullis C, Quance G, Lue FA. Nitrazepam for periodic movements in sleep (sleep-related myoclonus). Canadian Journal of Neurological Sciences 1986; 13: 5254.
  • 35
    Benes H, Kurella B, Kummer J, Kazenwadel J, Selzer R, Kohnen R. Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial. Sleep 1999; 22: 10731081.
  • 36
    Akpinar S. Restless legs syndrome treatment with dopaminergic drugs. Clinical Neuropharmacology 1987; 10: 6979.
  • 37
    Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988; 38: 18451848.
  • 38
    Trenkwalder C, Stiasny K, Pollmacher T, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995; 18: 681688.
  • 39
    Montplaisir J, Boucher S, Gosselin A, Poirier G, Lavigne G. Persistence of repetitive EEG arousals (K-alpha complexes) in RLS patients treated with L-DOPA. Sleep 1996; 19: 196199.
  • 40
    Collado-Seidel V, Kazenwadel J, Wetter TC, et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology 1999; 52: 285290.
  • 41
    Saletu M, Anderer P, Hogl B, et al. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome. Journal of Neural Transmission 2003; 110: 611626.
  • 42
    Walker SL, Fine A, Kryger MH. L-DOPA/carbidopa for nocturnal movement disorders in uremia. Sleep 1996; 19: 214218.
  • 43
    Kaplan PW, Allen RP, Buchholz DW, Walters JK. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 1993; 16: 717723.
  • 44
    Boivin DB, Montplaisir J, Poirier G. The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy. Clinical Neuropharmacology 1989; 12: 339345.
  • 45
    De Mello MT, Poyares DL, Tufik S. Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions. Spinal Cord 1999; 37: 634637.
  • 46
    Tergau F, Wischer S, Wolf C, Paulus W. Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine. Movement Disorders 2001; 16: 731735.
  • 47
    Walters AS, Hening WA, Kavey N, Chokroverty S, Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Annals of Neurology 1988; 24: 455458.
  • 48
    Stiasny-Kolster K, Benes H, Peglau I, et al. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology 2004; 63: 22722279.
  • 49
    Benes H, Heinrich CR, Ueberall MA, Kohnen R. Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. Sleep 2004; 27: 674682.
  • 50
    Trenkwalder C, Hundemer HP, Lledo A, et al. Efficacy of pergolide in treatment of restless legs syndrome: The PEARLS Study. Neurology 2004; 62: 13911397.
  • 51
    Staedt J, Wassmuth F, Ziemann U, Hajak G, Ruther E, Stoppe G. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa. Journal of Neural Transmission 1997; 104: 461468.
  • 52
    Pieta J, Millar T, Zacharias J, Fine A, Kryger M. Effect of pergolide on restless legs and leg movements in sleep in uremic patients. Sleep 1998; 21: 617622.
  • 53
    Boivin DB, Lorrain D, Montplaisir J. Effects of bromocriptine on periodic limb movements in human narcolepsy. Neurology 1993; 43: 21342136.
  • 54
    Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. Journal of Neurology, Neurosurgery and Psychiatry 2004a; 75: 9297.
  • 55
    Walters AS, Ondo W, Dreykluft T, Grunstein R, Lee D, Sethi K, TREAT RLS 2 Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Movement Disorders 2004; 19: 14141423.
  • 56
    Adler CH, Hauser RA, Sethi K, et al. Ropinirole for restless legs syndrome: a placebo-controlled crossover trial. Neurology 2004; 62: 14051407.
  • 57
    Allen R, Becker PM, Bogan R, et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 2004; 27: 907914.
  • 58
    Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999; 52: 938943.
  • 59
    Stiasny-Kolster K, Kohen R, Schollmayer E, Moller JC, Oertel WH, Rotigotine Sp 666 Study Group. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Movement Disorders 2004; 19: 14321438.
  • 60
    Pellecchia MT, Vitale C, Sabatini M, et al. Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release. Clinical Neuropharmacology 2004; 27: 178181.
  • 61
    Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993; 16: 327332.
  • 62
    Davis BJ, Rajput A, Rajput ML, Aul EA, Eichhorn GR. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. European Neurology 2000; 43: 7075.
  • 63
    Earley CJ, Heckler D, Allen RP. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Medicine 2004; 5: 231235.
  • 64
    Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep 1998; 21: 501505.
  • 65
    Evidente VG, Adler CH, Caviness JN, Hentz JG, Gwinn-Hardy K. Amantadine is beneficial in restless legs syndrome. Movement Disorders 2000; 15: 324327.
  • 66
    Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. American Journal of Kidney Diseases 2004; 43: 663670.
  • 67
    Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Movement Disorders 2002; 17: 10721076.
  • 68
    Polo-Kantola P, Rauhala E, Erkkola R, Irjala K, Polo O. Estrogen replacement therapy and nocturnal periodic limb movements: a randomized controlled trial. Obstetrics and Gynecology 2001; 97: 548554.
  • 69
    Broughton RJ, Fleming JAE, George CFP, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997; 49: 444451.
  • 70
    Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. American Journal of Kidney Diseases 2003; 41: 403410.
  • 71
    Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia related to dysthymia: polysomnographic and psychometric: comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology 2001; 44: 139149.
  • 72
    Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002; 26: 249260.
  • 73
    Guilleminault C, Mondini S, Montplaisir J, Mancuso J, Cobasko D, Dement WC. Periodic leg movement, L-dopa, 5-hydroxytryptophan, and L-tryptophan. Sleep 1987; 10: 393397.
  • 74
    Priano L, Albani G, Brioschi A, et al. Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. Neurological Sciences 2003; 24: 207208.
  • 75
    Haba-Rubio J, Staner L, Cornette F, et al. Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: a preliminary report. Neurophysiologie Clinique 2003; 33: 180184.
  • 76
    De Mello MT, Lauro FAA, Silva AC, Tufik S. Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects. Spinal Cord 1996; 34: 294296.
  • 77
    De Mello MT, Silva AC, Rueda AD, Poyares D, Tufik S. Correlation between K complex, periodic leg movements (PLM), and myoclonus during sleep in paraplegic adults before and after an acute physical activity. Spinal Cord 1997; 35: 248252.
  • 78
    De Mello MT, Silva AC, Esteves AM, Tufik S. Reduction of periodic leg movement in individuals with paraplegia following aerobic physical exercise. Spinal Cord 2002; 40: 646649.
  • 79
    Chesson AL, Jr, Wise M, Davila D, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999; 22: 961998.
  • 80
    Hening WA, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999; 22: 970999.
  • 81
    Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004; 27: 560583.
  • 82
    Garcia-Borreguero D, Larrosa O, Verger K, Masramon X, Hernandez G. Effects of gabapentin on restless legs syndrome accompanied by nocturnal pain: results of a double-blind, crossover study with polysomnographic control in 24 patients. European Journal of Neurology 2002; 9: 4950.
  • 83
    Larsen S, Telstad W, Sorensen O, Thom E, Stensrud P, Nyberg-Hansen R. Carbamazepine therapy in restless legs. Discrimination between responders and non-responders. Acta Medica Scandinavica 1985; 218: 223227.
  • 84
    Zucconi M, Coccagna G, Petronelli R, Gerardi R, Mondini S, Cirignotta F. Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment. Functional Neurology 1989; 4: 263271.
  • 85
    Perez-Bravo A. Utilidad del topiramato en el tratamiento del sindrome de piernas inquietas. Actas Espanolas de Psiquiatria 2004; 32: 132137.
  • 86
    Horiguchi J, Inami Y, Sasaki A, Nishimatsu O, Sukegawa T. Periodic leg movements in sleep with restless legs syndrome: effect of clonazepam treatment. The Japanese Journal of Psychiatry and Neurology 1992; 46: 727732.
  • 87
    Wetter TC, Trenkwalder C, Stiasny K, et al. Behandlung des idiopathischen und uramischen Restless-legs-Syndrom mit L-Dopa – Eine doppelblinde Cross-over-Studie. Wiener Medizinische Wochenschrift 1995; 145: 525527.
  • 88
    Collado-Seidel V. Treatment of the restless legs syndrome with a combination of standard and sustained release levodopa/benserazide (Madopar Depot): a double-blind controlled study. Pharmacopsychiatry 1997; 30: 158.
  • 89
    Trenkwalder C, Seidel VC, Kazenwadel J, et al. Treatment of the restless legs syndrome with a combination of standard and sustained-release levodopa/benserazide (Madopar Depot(R)): a double-blind controlled study. Journal of the Neurological Sciences 1997; 150: S204.
  • 90
    Montplaisir J, Godbout R, Poirier G, Bedard MA. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clinical Neuropharmacology 1986; 9: 456463.
  • 91
    Von Scheele C. Levodopa in restless legs. Lancet 1986; 2: 426427.
  • 92
    Becker PM, Jamieson AO, Brown WD. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep 1993; 16: 713716.
  • 93
    Guilleminault C, Cetel M, Philip P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 1993; 43: 445.
  • 94
    Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996; 19: 205213.
  • 95
    Earley CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996; 19: 801810.
  • 96
    Trenkwalder C, Collado-Seidel V, Kazenwadel J, et al. One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome? Movement Disorders 2003; 18: 11841189.
  • 97
    Garcia-Borreguero D, Serrano C, Larrosa O, Jose-Granizo J. Circadian effects of dopaminergic treatment in restless legs syndrome. Sleep Medicine 2004; 5: 413420.
  • 98
    Stiasny-Kolster K, Magerl W, Oertel WH, Moller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004; 127: 773782.
  • 99
    Stiasny K, Moller JC, Bodenschatz R, et al. Rotigotine CDS in the treatment of moderate to advanced stages of restless legs syndrome: a double-blind placebo-controlled study. Movement Disorders 2002; 17: S241.
  • 100
    Stiasny K, Uberall M, Oertel WH. Cabergoline in restless legs syndrome (RLS) – a double-blind placebo-controlled multicenter dose-finding trial. European Journal of Neurology 2002; 9: 50.
  • 101
    Stiasny-Kolster K, Oertel WH. Low-dose pramipexole in the management of restless legs syndrome. An open label trial. Neuropsychobiology 2004; 50: 6570.
  • 102
    Stiasny K, Robbecke J, Schuler P, Oertel WH. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline – an open clinical trial. Sleep 2000; 23: 349354.
  • 103
    Stiasny K. Clinical data on restless legs syndrome: a dose-finding study with cabergoline. European Neurology 2001; 46(Suppl. 1): 2426.
  • 104
    Stiasny K. Handling the problem of augmentation in restless legs syndrome (RLS). European Journal of Neurology 2001; 8: 15.
  • 105
    Zucconi M, Oldani A, Castronovo C, Ferini-Strambi L. Cabergoline is an effective single-drug treatment for restless legs syndrome: clinical and actigraphic evaluation. Sleep 2003; 26: 815818.
  • 106
    Trenkwalder C, Brandenburg U, Hundemer HP, et al. A randomized long-term placebo-controlled multicenter trial of pergolide in the treatment of restless legs syndrome with central evaluation of polysomnographic data. Neurology 2001; 56: A5A6.
  • 107
    Trenkwalder C, Brandenburg U, Hundemer HP, Lledo A, Quail D, Swieca J. A long-term controlled multicenter trial of pergolide in the treatment of restless legs syndrome with central evaluation of polysomnographic data. Journal of the Neurological Sciences 2001; 187: S432.
  • 108
    Hundemer HP, Trenkwalder C, Lledo A, et al. The safety of pergolide in the treatment of restless legs syndrome (RLS): results of a randomized long-term multicenter trial of pergolide in the treatment of RLS. Neurology 2001; 56: A20.
  • 109
    Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 52: 944950.
  • 110
    Tagaya H, Wetter TC, Winkelmann J, et al. Pergolide restores sleep maintenance but impairs sleep EEG synchronization in patients with restless legs syndrome. Sleep Medicine 2002; 3: 4954.
  • 111
    Staedt J, Hunerjager H, Ruther E, Stoppe G. Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide. Short communication. Journal of Neural Transmission 1998; 105: 265268.
  • 112
    Earley CJ, Yaffee JB, Allen RP. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 1998; 51: 15991602.
  • 113
    Stiasny K, Wetter TC, Winkelmann J, et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 2001; 56: 13991402.
  • 114
    Benes H, Deissler A, Clarenbach P, Rodenbeck A, Hajak G. Lisuride in the management of restless legs syndrome. Movement Disorders 2000; 15: S134S135.
  • 115
    Sonka K, Pretl M, Kranda K. Management of restless legs syndrome by the partial D2-agonist terguride. Sleep Medicine 2003; 4: 455457.
  • 116
    Estivill E, De La Fuente V. Uso de ropinirol como tratamiento del sindrome de piernas inquietas. Revista de Neurologia 1999; 28: 962963.
  • 117
    Estivill E, De La Fuente V. Eficacia del ropinirol como tratamiento del insomnio cronico secundario al sindrome de piernas inquietas: datos polisomnograficos. Revista de Neurologia 1999; 29: 805807.
  • 118
    Ondo W. Ropinirole for restless legs syndrome. Movement Disorders 1999; 14: 138140.
  • 119
    Saletu B, Gruber G, Saletu M, et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology 2000; 41: 181189.
  • 120
    Saletu M, Anderer P, Saletu B, et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 2000; 41: 190199.
  • 121
    Watts RL, Freeman A, Rye DB, Bliwise DL, Krulewicz S. Ropinirole for restless legs syndrome. Movement Disorders 2000; 15: S134.
  • 122
    Freeman A, Rye DB, Bliwise D, Chakravorty S, Krulewicz S, Watts RL. Ropinirole for restless legs syndrome (RLS): an open label and double blind placebo-controlled study. Neurology 2001; 56: A5.
  • 123
    Ahmed I. Ropinirole in restless leg syndrome. Missouri Medicine 2002; 99: 500501.
  • 124
    Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Pramipexole alleviates sensory and motor symptoms of restless legs syndrome. Neurology 1998; 51: 311312.
  • 125
    Becker PM, Ondo W, Sharon D. Encouraging initial response of restless legs syndrome to pramipexole. Neurology 1998; 51: 12211223.
  • 126
    Lin SC, Kaplan J, Burger CD, Fredrickson PA. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clinic Proceedings 1998; 73: 497500.
  • 127
    Montplaisir J, Denesle R, Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study. European Journal of Neurology 2000; 7(Suppl. 1): 2731.
  • 128
    Saletu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. European Archives of Psychiatry and Clinical Neuroscience 2002; 252: 185194.
  • 129
    Manconi M, Casetta I, Govoni V, Cesnik E, Ferini-Strambi L, Granieri E. Pramipexole in restless legs syndrome. Evaluation by suggested immobilization test. Journal of Neurology 2003; 250: 14941495.
  • 130
    Hening W, Walters AS, Wagner ML, et al. Successful oxycodone therapy for the restless legs syndrome: a double-blind study. Canadian Journal of Neurological Sciences 1993; 20: S212.
  • 131
    Lauerma H, Markkula J. Treatment of restless legs syndrome with tramadol: an open study. Journal of Clinical Psychiatry 1999; 60: 241244.
  • 132
    Van Dijk JG, Bollen EL, Slootweg J, Van Der Meer CM, Durian FW, Zwinderman AH. Geen verschil in werkzaamheid tussen hydrokinine en placebo bij het ‘restless legs’-syndroom. Nederlands Tijdschrift voor Geneeskunde 1991; 135: 759763.
  • 133
    Ausserwinkler M, Schmidt P. Clonidine is effective in the treatment of ‘restless leg’ syndrome in chronic uraemic patients. Nephrology, Dialysis, Transplantation 1988; 3: 530.
  • 134
    Ausserwinkler M, Schmidt P. Clonidine is effective in the treatment of ‘restless leg’ syndrome in chronic uraemia patients. Nephrology, Dialysis, Transplantation 1989; 4: 149.
  • 135
    Micozkadioglu H, Ozdemir FN, Kut A, Sezer S, Saatci U, Haberal M. Gabapentin versus levodopa for the treatment of restless legs syndrome in hemodialysis patients: an open-label study. Renal Failure 2004; 26: 393397.
  • 136
    Galvez-Jimenez N, Khan T. Ropinirole and restless legs syndrome. Movement Disorders 1999; 14: 890892.
  • 137
    Miranda M, Fabres L, Kagi M, et al. Tratamiento del sindrome de piernas inquietas en pacientes uremicos en dialisis con pramipexole: resultados preliminares. Revista Medica de Chile 2003; 131: 700701.
  • 138
    Miranda M, Kagi M, Fabres L, et al. Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis. Neurology 2004; 62: 831832.
  • 139
    Holman AJ, Neiman RA, Ettlinger RE. Preliminary efficacy of the dopamine agonist, pramipexole, for fibromyalgia: the first, open label, multicenter experience. Journal of Musculoskeletal Pain 2004; 12: 6974.
  • 140
    O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age and Ageing 1994; 23: 200203.
  • 141
    Evidente VG. Piribedil for restless legs syndrome: a pilot study. Movement Disorders 2001; 16: 579581.
  • 142
    Ehrenberg BL, Eisensehr I, Corbett KE, Crowley PF, Walters AS. Valproate for sleep consolidation in periodic limb movement disorder. Journal of Clinical Psychopharmacology 2000; 20: 574578.
  • 143
    Nishimatsu O, Horiguchi J, Inami Y, Sukegawa T, Sasaki A. Periodic limb movement disorder in neuroleptic-induced akathisia. Kobe Journal of Medical Sciences 1997; 43: 169177.
  • 144
    Roehrs T, Zorick F, Wittig R, Roth T. Efficacy of a reduced triazolam dose in elderly insomniacs. Neurobiology of Aging 1985; 6: 293296.
  • 145
    Bonnet MH, Arand DL. The use of triazolam in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness. Journal of Gerontology 1990; 45: M139M144.
  • 146
    Kaplan PW, Allen RP, Buchholz DW, Walters JK. Double-blind comparison of L-dopa versus propoxyphene in patients with periodic limb movements in sleep. Electroencephalography and Clinical Neurophysiology 1991; 79: 32P.
  • 147
    Bedard MA, Montplaisir J, Godbout R. Effect of L-dopa on periodic movements in sleep in narcolepsy. European Neurology 1987; 27: 3538.
  • 148
    De Mello MT, Esteves AM, Tufik S. Comparison between dopaminergic agents and physical exercise as treatment for periodic limb movements in patients with spinal cord injury. Spinal Cord 2004; 42: 218221.
  • 149
    Boivin DB, Montplaisir J, Lambert C. Effects of bromocriptine in human narcolepsy. Clinical Neuropharmacology 1993; 16: 120126.
  • 150
    Hogl B, Rothdach A, Wetter TC, Trenkwalder C. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 2003; 28: 18661870.
  • 151
    Saletu M, Anderer P, Saletu B, et al. Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole. Human Psychopharmacology 2001; 16: 177187.
  • 152
    Fantini ML, Gagnon J, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003; 61: 14181420.
  • 153
    Buysse DJ, Reynolds CF, III, Hoch CC, et al. Longitudinal effects of nortriptyline on EEG sleep and the likelihood of recurrence in elderly depressed patients. Neuropsychopharmacology 1996; 14: 243252.
  • 154
    Nofzinger EA, Fasiczka A, Berman S, Thase ME. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. Journal of Clinical Psychiatry 2000; 61: 858862.
  • 155
    Grewal M, Hawa R, Shapiro C. Treatment of periodic limb movements in sleep with selegiline HCl. Movement Disorders 2002; 17: 398401.
  • 156
    Yamashiro Y, Kryger MH. Acute effect of nasal CPAP on periodic limb movements associated with breathing disorders during sleep. Sleep 1994; 17: 172175.
  • 157
    Briellmann RS, Mathis J, Bassetti C, Gugger M, Hess CW. Patterns of muscle activity in legs in sleep apnea patients before and during nCPAP therapy. European Neurology 1997; 38: 113118.
  • 158
    Kotterba S, Clarenbach P, Bommel W, Rasche K. Periodic leg movements in patients with obstructive sleep apnea syndrome during nCPAP therapy. Somnologie 2000; 4: 9395.
  • 159
    Scholle S, Scholle HC, Zwacka G. Periodic leg movements and sleep-disordered breathing in children. Somnologie 2001; 5: 153158.
  • 160
    Baran AS, Richert AC, Douglass AB, May W, Ansarin K. Change in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressure. Sleep 2003; 26: 717720.
  • 161
    Guilleminault C, Flagg W. Effect of baclofen on sleep-related periodic leg movements. Annals of Neurology 1984; 15: 234239.
  • 162
    Bedard MA, Montplaisir J, Godbout R, Lapierre O. Nocturnal gamma-hydroxybutyrate. Effect on periodic leg movements and sleep organization of narcoleptic patients. Clinical Neuropharmacology 1989; 12: 2936.
  • 163
    Kovacevic-Ristanovic R, Cartwright RD, Lloyd S. Nonpharmacologic treatment of periodic leg movements in sleep. Archives of Physical Medicine and Rehabilitation 1991; 72: 385389.
  • 164
    Lavie P, Nahir M, Lorber M, Scharf Y. Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis patients: lack of association between clinical improvement and effects on sleep. Arthritis and Rheumatism 1991; 34: 655659.
  • 165
    Benz RL, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (the SLEEPO study). American Journal of Kidney Diseases 1999; 34: 10891095.
  • 166
    Kunz D, Bes F. Exogenous melatonin in periodic limb movement disorder: an open clinical trial and a hypothesis. Sleep 2001; 24: 183187.
  • 167
    Campos H, Tufik S, Bittencourt L, Haidar M, Baracat EC. Progeston reduces periodic leg movements in menopause. Climacteric 2002; 5: 157 (abstract).
  • 168
    Saletu A, Gritsch F, Mailath-Pokorny G, Gruber G, Anderer P, Saletu B. Objektivierung der Therapieeffizienz eines neuartigen mandibularen Protrusionsbehelfs fur Schnarchen und schlafbezogene Atmungsstorungen mittels Polysomnographie. Wiener Klinische Wochenschrift 2002; 114: 807815.
  • 169
    Michalsen A, Schlegel F, Rodenbeck A, et al. Effects of short-term modified fasting on sleep patterns and daytime vigilance in non-obese subjects: results of a pilot study. Annals of Nutrition and Metabolism 2003; 47: 194200.
  • 170
    Simakajornboon N, Gozal D, Vlasic V, Mack C, Sharon D, McGinley BM. Periodic limb movements in sleep and iron status in children. Sleep 2003; 26: 735738.
  • 171
    Cicolin A, Lopiano L, Zibetti M, et al. Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Medicine 2004; 5: 207210.
  • 172
    Brenning R. Enantaldehydes and furaldehydes in molimina crurum nocturna including ‘restless legs’. A comparative trial with carbacholine, inositolnicotinate, and placebo. Nordisk Medicin 1969; 81: 528534.
  • 173
    Christiansen I. Mesionositolhexanikotinat (Hexanicit) og pentaerytritoltetranikotinat (Bufon) ved restless legs. Ugeskrift for Laeger 1970; 132: 14751476.
  • 174
    Hurlimann F. Restless legs and crampi in the night. Double blind study with circonyl in patients with defective peripheric arterial circulation. Schweizerische Rundschau fur Medizin Praxis 1974; 63: 194195.
  • 175
    Noseda A, Nouvelle M, Lanquart JR, et al. High leg motor activity in sleep apnea hypopnea patients: efficacy of clonazepam combined with nasal CPAP on polysomnographic variables. Respiratory Medicine 2002; 96: 693699.
  • 176
    Sorensen O, Telstad W. Carbamazepin (Tegretol) ved restless legs syndrom. Tidsskrift for den Norske Laegeforening 1984; 104: 20932095.
  • 177
    Handwerker J-VJ, Palmer RF. Clonidine in the treatment of ‘restless leg’ syndrome. New England Journal of Medicine 1985; 313: 12281229.
  • 178
    Bamford CR, Sandyk R. Failure of clonidine to ameliorate the symptoms of restless legs syndrome. Sleep 1987; 10: 398399.
  • 179
    Zoe A, Wagner ML, Walters AS. High-dose clonidine in a case of restless legs syndrome. Annals of Pharmacotherapy 1994; 28: 878881.
  • 180
    Riemann D, Gann H, Dressing H. Restless legs syndrome and periodic leg movements in sleep. TW Neurologie Psychiatrie 1995; 9: 1951.
  • 181
    Merren MD. Gabapentin for treatment of pain and tremor: a large case series. Southern Medical Journal 1998; 91: 739744.
  • 182
    Morgan LK. Restless limbs: a commonly overlooked symptom controlled by ‘Valium’. Medical Journal of Australia 1967; 2: 589594.
  • 183
    Matthews WB. Treatment of the restless legs syndrome with clonazepam. British Medical Journal 1979; 1: 751.
  • 184
    Boghen D. Successful treatment of restless legs with clonazepam. Annals of Neurology 1980; 8: 341.
  • 185
    Montplaisir J, Godbout R, Boghen D, DeChamplain J, Young SN, Lapierre G. Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study. Neurology 1985; 35: 130134.
  • 186
    Tollefson G, Erdman C. Triazolam in the restless legs syndrome. Journal of Clinical Psychopharmacology 1985; 5: 361362.
  • 187
    Scharf MB, Brown L, Hirschowitz J. Possible efficacy of alprazolam in restless leg syndrome. The Hillside Journal of Clinical Psychiatry 1986; 8: 214223.
  • 188
    Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. American Journal of Medicine 1996; 100: 333337.
  • 189
    Stautner A, Stiasny-Kolster K, Collado-Seidel V, Bucher SF, Oertel WH, Trenkwalder C. Comparison of idiopathic and uremic restless legs syndrome: results of data base of 134 patients. Movement Disorders 1996; 11: S98.
  • 190
    Bezerra ML, Martinez JV. Zolpidem in restless legs syndrome. European Neurology 2002; 48: 180181.
  • 191
    Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Archives of Neurology 1982; 39: 739.
  • 192
    Von Scheele C, Kempi V. Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up. Archives of Neurology 1990; 47: 12231224.
  • 193
    Lauerma H. Nocturnal wandering caused by restless legs and short-acting benzodiazepines. Acta Psychiatrica Scandinavica 1991; 83: 492493.
  • 194
    Oechsner M. Idiopathic restless legs syndrome: combination therapy with levodopa and ropinirole. Aktuelle Neurologie 1998; 25: 190192.
  • 195
    Kumar VG, Bhatia M, Tripathi M, Srivastava AK, Jain S. Restless legs syndrome: diagnosis and treatment. Journal of the Association of Physicians of India 2003; 51: 782783.
  • 196
    Silber MH, Shepard J-WJ, Wisbey JA. Pergolide in the management of restless legs syndrome: an extended study. Sleep 1997; 20: 878882.
  • 197
    Noel S, Korri H, Vanderheyden JE. Low dosage of pergolide in the treatment of restless legs syndrome. Acta Neurologica Belgica 1998; 98: 5253.
  • 198
    Winkelmann J, Wetter TC, Stiasny K, Oertel WH, Trenkwalder C. Treatment of restless leg syndrome with pergolide – an open clinical trial. Movement Disorders 1998; 13: 566569.
  • 199
    Benes H. Idiopathisches Restless-legs-Syndrom: Behandlung mit Lisurid. Nervenheilkunde 2001; 20: 119122.
  • 200
    Danoff SK, Grasso ME, Terry PB, Flynn JA. Pleuropulmonary disease due to pergolide use for restless legs syndrome. Chest 2001; 120: 313316.
  • 201
    Bassetti C, Clavadetscher S, Gugger M, Hess CW. Pergolide-associated ‘sleep attacks’ in a patient with restless legs syndrome. Sleep Medicine 2002; 3: 275277.
  • 202
    Stiasny K, Moller JC, Oertel WH. Safety of pramipexole in patients with restless legs syndrome. Neurology 2000; 55: 15891590.
  • 203
    Ferini-Strambi L. Restless legs syndrome augmentation and pramipexole treatment. Sleep Medicine 2002; 3: S23S25.
  • 204
    Teive HA, De Quadros A, Barros FC, Werneck LC. Sindrome das pernas inquietas com heranca autossomica dominante piorada pelo uso de mirtazapina: relato de caso. Arquivos de Neuro-Psiquiatria 2002; 60: 10251029.
  • 205
    Silber MH, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep 2003; 26: 819821.
  • 206
    Winkelman JW, Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Medicine 2004; 5: 914.
  • 207
    Trzepacz PT, Violette EJ, Sateia MJ. Response to opioids in three patients with restless legs syndrome. American Journal of Psychiatry 1984; 141: 993995.
  • 208
    Hening WA, Walters A, Kavey N, Gidro-Frank S, Cote L, Fahn S. Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids. Neurology 1986; 36: 13631366.
  • 209
    Walters A, Hening W, Cote L, Fahn S. Dominantly inherited restless legs with myoclonus and periodic movements of sleep: a syndrome related to the endogenous opiates? Advances in Neurology 1986; 43: 309319.
  • 210
    Sandyk R, Bernick C, Lee SM, Stern LZ, Iacono RP, Bamford CR. L-dopa in uremic patients with the restless legs syndrome. International Journal of Neuroscience 1987; 35: 233235.
  • 211
    Sandyk R, Bamford CR, Gillman MA. Opiates in the restless legs syndrome. International Journal of Neuroscience 1987; 36: 99104.
  • 212
    Montplaisir J, Lorrain D, Godbout R. Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. European Neurology 1991; 31: 4143.
  • 213
    Vahedi H, Kuchle M, Trenkwalder C, Krenz CJ. Peridurale Morphiumanwendung bei Restless-Legs-Status. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 1994; 29: 368370.
  • 214
    Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Movement Disorders 2001; 16: 11051109.
  • 215
    Jakobsson B, Ruuth K. Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery. Acta Anaesthesiologica Scandinavica 2002; 46: 114117.
  • 216
    Ayres SJ, Mihan R. Leg cramps (systremma) and ‘restless legs’ syndrome. Response to vitamin E (tocopherol). California Medicine 1969; 111: 8791.
  • 217
    Blattler W, Muhlemann M. Restless legs und nachtliche Beinkrampfe – Vergessenes zur Diagnose – Neues zur Therapie. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine 1982; 112: 115117.
  • 218
    Mountifield JA. Restless leg syndrome relieved by cessation of smoking. CMAJ 1985; 133: 426427.
  • 219
    Ha HC. Regional intravenous analgesia for restless legs syndrome. Pain Clinic 1988; 2: 121123.
  • 220
    Sandyk R, Kwo-on-Yuen PF, Bamford CR. The effects of baclofen in the restless legs syndrome: evidence for endogenous opioid involvement. Journal of Clinical Psychopharmacology 1988; 8: 440441.
  • 221
    Dimmitt SB, Riley GJ. Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms. Archives of Internal Medicine 2000; 160: 712.
  • 222
    Hu J. Acupuncture treatment of restless leg syndrome. Journal of Traditional Chinese Medicine 2001; 21: 312316.
  • 223
    Kapur N, Friedman R. Oral ketamine: a promising treatment for restless legs syndrome. Anesthesia and Analgesia 2002; 94: 15581559.
  • 224
    Lin Z. How to treat restless leg syndrome with traditional Chinese medicine? Journal of Traditional Chinese Medicine 2003; 23: 306307.
  • 225
    Strang RR. The symptom of restless legs. Medical Journal of Australia 1967; 1: 12111213.
  • 226
    Lipinski JF, Zubenko GS, Barreira P, Cohen BM. Propranolol in the treatment of neuroleptic-induced akathisia. Lancet 1983; 2: 685686.
  • 227
    Derom E, Elinck W, Buylaert W, Van Der Straeten M. Which beta-blocker for the restless leg? Lancet 1984; 1: 857.
  • 228
    Ginsberg HN. Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawal. American Journal of Psychiatry 1986; 143: 938.
  • 229
    Bastani B, Westervelt FB. Effectiveness of clonidine in alleviating the symptoms of ‘restless legs’. American Journal of Kidney Diseases 1987; 10: 326.
  • 230
    Cavatorta F, Vagge R, Solari P, Queirolo C. Risultati preliminari con clonidina nella sindrome delle gambe senza riposo in due pazienti uremici emodializzati. Minerva Urologica e Nefrologica 1987; 39: 93.
  • 231
    Novelli G, Mediati RD, Casali R, Palermo P. Treatment of ‘restless legs syndrome’ with gabapentin. Pain Clinic 2000; 12: 6163.
  • 232
    Read DJ, Feest TG, Nassim MA. Clonazepam: effective treatment for restless legs syndrome in uraemia. British Medical Journal (Clinical Research Edition) 1981; 283: 885886.
  • 233
    Salvi F, Montagna P, Plasmati R, et al. Restless legs syndrome and nocturnal myoclonus: initial clinical manifestation of familial amyloid polyneuropathy. Journal of Neurology, Neurosurgery and Psychiatry 1990; 53: 522525.
  • 234
    Horiguchi J, Yamashita H, Mizuno S, et al. Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome. International Clinical Psychopharmacology 1999; 14: 3336.
  • 235
    Bruno RL. Abnormal movements in sleep as a post-polio sequelae. American Journal of Physical Medicine and Rehabilitation 1998; 77: 339344.
  • 236
    Walters AS, Mandelbaum DE, Lewin DS, Kugler S, England SJ, Miller M. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. Pediatric Neurology 2000; 22: 182186.
  • 237
    Sharif AA. Entacapone in restless legs syndrome. Movement Disorders 2002; 17: 421.
  • 238
    Scherbaum N, Stuper B, Bonnet U, Gastpar M. Transient restless legs-like syndrome as a complication of opiate withdrawal. Pharmacopsychiatry 2003; 36: 7072.
  • 239
    Lipinski JF, Sallee FR, Jackson C, Sethuraman G. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Movement Disorders 1997; 12: 402407.
  • 240
    Brown LK, Heffner JE, Obbens EA. Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen. Sleep 2000; 23: 591594.
  • 241
    Hanna PA, Kumar S, Walters AS. Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs. Clinical Neuropharmacology 2004; 27: 8789.
  • 242
    Estivill E, Fuente-Panell V, Segarra-Isern F, Albares-Tendero J. Sindrome de piernas inquietas en un paciente con amputacion de ambas piernas. Revista de Neurologia 2004; 39: 536538.
  • 243
    Lauerma H, Markkula J, Hyvonen H, Kyyronen K. Idiopathic restless legs syndrome and psychoses. Nordic Journal of Psychiatry 1997; 51: 205.
  • 244
    Burns KE. Use of tramadol to control restless legs syndrome after orthopedic surgery. Hospital Pharmacy 2000; 35: 673.
  • 245
    Freye E, Levy J. Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study. European Journal of Pain 2000; 4: 307311.
  • 246
    Nordlander NB. Therapy in restless legs. Acta Medica Scandinavica 1953; 145: 453457.
  • 247
    Popkin RJ. Orphenadrine citrate (Norflex) for the treatment of ‘restless legs’ and related syndromes. Journal of the American Geriatrics Society 1971; 19: 7679.
  • 248
    Morgan LK. Letter: Restless legs: precipitated by beta blockers, relieved by orphenadrine. Medical Journal of Australia 1975; 2: 753.
  • 249
    Botez MI, Fontaine F, Botez T, Bachevalier J. Folate-responsive neurological and mental disorders: report of 16 cases. Neuropsychological correlates of computerized transaxial tomography and radionuclide cisternography in folic acid deficiencies. European Neurology 1977; 16: 230246.
  • 250
    Botez MI, Cadotte M, Beaulieu R, Pichette LP, Pison C. Neurologic disorders responsive to folic acid therapy. Canadian Medical Association Journal 1976; 115: 217223.
  • 251
    Yatzidis H, Koutsicos D, Agroyannis B, Papastephanidis C, Plemenos M, Delatola Z. Biotin in the management of uremic neurologic disorders. Nephron 1984; 36: 183186.
  • 252
    Sandyk R. L-Tryptophan in the treatment of restless legs syndrome. American Journal of Psychiatry 1986; 143: 554555.
  • 253
    Yasuda T, Nishimura A, Katsuki Y, Tsuji Y. Restless legs syndrome treated successfully by kidney transplantation – a case report. Clinical Transplants 1986; 12: 138.
  • 254
    Sandyk R, Iacono RP, Bamford CR. Spinal cord mechanisms in amitriptyline responsive restless legs syndrome in Parkinson's disease. International Journal of Neuroscience 1988; 38: 121124.
  • 255
    Kerr PG, Van Bakel C, Dawborn JK. Assessment of the symptomatic benefit of cool dialysate. Nephron 1989; 52: 166169.
  • 256
    O'Keeffe ST, Noel J, Lavan JN. Restless legs syndrome in the elderly. Postgraduate Medical Journal 1993; 69: 701703.
  • 257
    Kanter AH. The effect of sclerotherapy on restless legs syndrome. Dermatologic Surgery 1995; 21: 328332.
  • 258
    Reuter I, Ellis CM, Ray-Chaudhuri K. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta Neurologica Scandinavica 1999; 100: 163167.
  • 259
    Rye DB, DeLong MR. Amelioration of sensory limb discomfort of restless legs syndrome by pallidotomy. Annals of Neurology 1999; 46: 800801.
  • 260
    Ishizu T, Ohyagi Y, Furuya H, et al. A patient with restless legs syndrome/periodic limb movement successfully treated by wearing a lumbar corset. Rinsho Shinkeigaku. Clinical Neurology 2001; 41: 438441.
  • 261
    Kryger MH, Otake K, Foerster J. Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers. Sleep Medicine 2002; 3: 127132.
  • 262
    Silber MH, Richardson JW. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clinic Proceedings 2003; 78: 5254.
  • 263
    McLean AJ. The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome. Sleep 2004; 27: 1022.
  • 264
    Ware JC, Blumoff R, Pittard JT. Peripheral vasoconstriction in patients with sleep related periodic leg movements. Sleep 1988; 11: 182186.
  • 265
    Laschewski F, Sanner B, Konermann M, Kreuzer I, Horstensmeyer D, Sturm A. Ausgepragte Hypersomnie einer 13jahrigen bei periodic leg movement. Pneumologie 1997; 3(Suppl. 51): 725728.
  • 266
    Staedt J, Stoppe G, Riemann H, Hajak G, Ruther E, Riederer P. Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): two case reports. Journal of Neural Transmission 1996; 103: 355361.
  • 267
    Oshtory MA, Vijayan N. Clonazepam treatment of insomnia due to sleep myoclonus. Archives of Neurology 1980; 37: 119120.
  • 268
    Rousseau JJ, Debatisse DF. Etude clinique et polygraphique de deux observations de ‘nocturnal myoclonus’ sensibles au clonazepam. Acta Neurologica Belgica 1985; 85: 318326.
  • 269
    Guilleminault C, Crowe C, Quera-Salva MA, Miles L, Partinen M. Periodic leg movement, sleep fragmentation and central sleep apnoea in two cases: reduction with clonazepam. European Respiratory Journal 1988; 1: 762765.
  • 270
    Romano TJ. Pharmacotherapy. Presence of nocturnal myoclonus in patients with fibromyalgia syndrome. American Journal of Pain Management 1999; 9: 85.
  • 271
    Malek-Ahmadi P. Bupropion, periodic limb movement disorder, and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 1999; 38: 637638.
  • 272
    Leonhardt M, Abele M, Klockgether T, Dichgans J, Weller M. Pathological yawning (chasm) associated with periodic leg movements in sleep: cure by levodopa. Journal of Neurology 1999; 246: 621622.
  • 273
    Picchietti DL, Walters AS. Moderate to severe periodic limb movement disorder in childhood and adolescence. Sleep 1999; 22: 297300.
  • 274
    Rodrigues RN, Silva AA. Sonolencia diurna excessiva pos-traumatismo de cranio: associacao com movimentos periodicos de pernas e disturbio de comportamento do sono REM: relato de caso. Arquivos de Neuro-Psiquiatria 2002; 60: 656660.
  • 275
    Santamaria J, Iranzo A, Tolosa E. Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep. Sleep Medicine 2003; 4: 153155.
  • 276
    Kavey N, Walters AS, Hening W, Gidro-Frank S. Opioid treatment of periodic movements in sleep in patients without restless legs. Neuropeptides 1988; 11: 181184.
  • 277
    Ancoli-Israel S, Seifert AR, Lemon M. Thermal biofeedback and periodic movements in sleep: patients’ subjective reports and a case study. Biofeedback and Self Regulation 1986; 11: 177188.
  • 278
    Hanly P, Zuberi N. Periodic leg movements during sleep before and after heart transplantation. Sleep 1992; 15: 489492.
  • 279
    Lee MS, Choi YC, Lee SH, Lee SB. Sleep-related periodic leg involvements associated with spinal cord lesions. Movement Disorders 1996; 11: 719722.
  • 280
    Paradiso G, Khan F, Chen R. Effects of apomorphine on flexor reflex and periodic limb movement. Movement Disorders 2002; 17: 594597.
  • 281
    Gulden J. Levodopa in the treatment of restless legs syndrome. Fortschritte der Medizin 1994; 112: 6162.
  • 282
    Hain C. Development of opioid dependence in a not diagnosed restless legs syndrome. Psychiatrische Praxis 2002; 29: 321323.
  • 283
    Horiguchi J, Inami Y, Miyoshi N, Kakimoto Y. Restless legs syndrome in four parkinsonian patients treated with amantadine. Rinsho Shinkeigaku. Clinical Neurology 1985; 25: 153156.
  • 284
    Kastin AJ, Kullander S, Borglin NE, et al. Extrapigmentary effects of melanocyte-stimulating hormone in amenorrhoeic women. Lancet 1968; 1: 10071010.
  • 285
    Nassr DG. Paradoxical response to nitrazepam in a patient with hypersomnia secondary to nocturnal myoclonus. Journal of Clinical Psychopharmacology 1986; 6: 121122.
  • 286
    Petiau C, Zamagni M, Trautmann D, Sforza E, Krieger J. Periodic movements during sleep syndrome. Journal de medecine de Strasbourg 1995; 26: 166169.
  • 287
    Satzger-Harsch U. Current studies: therapy with L-dopa/benserazide relieves excruciating symptoms in restless leg syndrome. Ärztliche Praxis Neurologie Psychiatrie 1998; 11: 40.
  • 288
    Schwarz J, Trenkwalder C. Restless legs syndrome: treatment with L-dopa or L-dopa slow release preparations. Aktuelle Neurologie 1996; 23: 2629.
  • 289
    Staedt J, Stoppe G, Kogler A, et al. Nachtliches Myoklonie-Syndrom (NMS) und Restless-Legs-Syndrom (RLS) – Ubersicht und Fallbeschreibung. Fortschritte der Neurologie-Psychiatrie 1994; 62: 8893.
  • 290
    Stiasny K. Restless legs syndrome: sometimes are hot and cold showers sufficient. Ärztliche Praxis Neurologie Psychiatrie 1999; 3: 3840.
  • 291
    Trenkwalder C. Dyskinesia on dopaminergic therapy for restless legs syndrome? Internistische Praxis 2003; 43: 99100.
  • 292
    Vaskivskyj M. Vliv hyperemizujici vodolecby na syndrom neklidnych nohou. Fysiatricky a Reumatologicky Vestnik 1973; 51: 308309.